Coordinated activities of multiple myc-dependent and myc-independent biosynthetic pathways in hepatoblastoma

Journal of Biological Chemistry

Volumn 291, Issue 51, 2016, Pages 26241-26251

  Donna, Beer Stolz ^b   Wang, Huabo ^a   Lu, Jie ^a   Edmunds, Lia R ^a   Kulkarni, Sucheta ^a   Dolezal, James ^a   Tao, Junyan ^b   Ranganathan, Sarangarajan ^a   Jackson, Laura ^a   Fromherz, Marc ^a   Uppala, Radha ^a   Bharathi, Sivakama ^a   Monga, Satdarshan P ^b   Goetzman, Eric S ^a   Prochownik, Edward V ^a,b,c  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLATION; BIOSYNTHESIS; ENCODING (SYMBOLS); ENZYMES; GENE EXPRESSION; GENES; METABOLISM; PROTEINS; TUMORS;

BIOSYNTHETIC PATHWAY; COORDINATED ACTIVITY; DEHYDROGENASE ACTIVITY; GENE EXPRESSION PROFILING; HEPATOCYTE PROLIFERATIONS; OXIDATIVE FUNCTIONS; RIBOSOMAL PROTEINS; SIGNALING PATHWAYS;

FATTY ACIDS;

FATTY ACID; MYC PROTEIN; ACETYL COENZYME A; ADENOSINE TRIPHOSPHATE; MYC PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DOWN REGULATION; FATTY ACID OXIDATION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GLYCOLYSIS; HEPATOBLASTOMA; IN VIVO STUDY; LIPID METABOLISM; LIVER CARCINOGENESIS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; ANIMAL; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; LIVER TUMOR; METABOLISM;

ACETYL COENZYME A; ADENOSINE TRIPHOSPHATE; ANIMALS; ENERGY METABOLISM; FATTY ACIDS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOBLASTOMA; LIVER NEOPLASMS; MICE; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 85006351483     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M116.754218     Document Type: Article

References (50)

1. De Ioris, M., Brugieres, L., Zimmermann, A., Keeling, J., Brock, P., Maibach, R., Pritchard, J., Shafford, L., Zsiros, J., Czaudzerna, P., and Perilongo, G. (2008) Hepatoblastoma with a low serum Β-fetoprotein level at diagnosis: The SIOPEL group experience. Eur. J. Cancer 44, 545-550.
2. Heck, J. E., Meyers, T. J., Lombardi, C., Park, A. S., Cockburn, M., Reynolds, P., and Ritz, B. (2013) Case-control study of birth characteristics and the risk of hepatoblastoma. Cancer Epidemiol. 37, 390-395.
3. Hamada, Y., Takada, K., Fukunaga, S., and Hioki, K. (2003) Hepatoblastoma associated with Beckwith-Wiedemann syndrome and hemihypertrophy. Pediatr. Surg. Int. 19, 112-114.
4. Spector, L. G., and Birch, J. (2012) The epidemiology of hepatoblastoma. Pediatr. Blood Cancer 59, 776-779.
5. Karim, R., Tse, G., Putti, T., Scolyer, R., and Lee, S. (2004) The significance of the Wnt pathway in the pathology of human cancers. Pathology 36, 120-128.
6. Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., and Clevers, H. (1997) Constitutive transcriptional activation by a Β-catenin-Tcf complex in APC-/- colon carcinoma. Science 275, 1784-1787.
7. Monga, S. P. (2015) -Catenin signaling and roles in liver homeostasis, injury, and tumorigenesis. Gastroenterology 148, 1294-1310.
8. White, B. D., Chien, A. J., and Dawson, D. W. (2012) Dysregulation of Wnt/-catenin signaling in gastrointestinal cancers. Gastroenterology 142, 219-232.
9. Armengol, C., Cairo, S., Fabre, M., and Buendia, M. A. (2011) Wnt signaling and hepatocarcinogenesis: The hepatoblastoma model. Int. J. Biochem. Cell Biol. 43, 265-270.
10. Tao, J., Calvisi, D. F., Ranganathan, S., Cigliano, A., Zhou, L., Singh, S., Jiang, L., Fan, B., Terracciano, L., Armeanu-Ebinger, S., Ribback, S., Dombrowski, F., Evert, M., Chen, X., and Monga, S. P. (2014) Activation of -catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice. Gastroenterology 147, 690-701.
11. Sylvester, K. G., and Colnot, S. (2014) Hippo/YAP, Β-catenin, and the cancer cell: A "menage a trois" in hepatoblastoma. Gastroenterology 147, 562-565.
12. Kango-Singh, M., and Singh, A. (2009) Regulation of organ size: insights from the Drosophila Hippo signaling pathway. Dev. Dyn. 238, 1627-1637.
13. Huang, J., Wu, S., Barrera, J., Matthews, K., and Pan, D. (2005) The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP. Cell 122, 421-434.
14. Pan, D. (2010) The hippo signaling pathway in development and cancer. Dev. Cell 19, 491-505.
15. Cairo, S., Armengol, C., and Buendia, M. A. (2012) Activation of Wnt and Myc signaling in hepatoblastoma. Front. Biosci. (Elite Ed.) 4, 480-486.
16. Ranganathan, S., Tan, X., and Monga, S. P. (2005) Β-Catenin and Met deregulation in childhood hepatoblastomas. Pediatr. Dev. Pathol. 8, 435-447.
17. Dang, C. V. (2010) Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. Cancer Res. 70, 859-862.
18. Dang, C. V. (2011) Therapeutic targeting of Myc-reprogrammed cancer cell metabolism. Cold Spring Harb. Symp. Quant. Biol. 76, 369-374.
19. Campbell, K. J., and White, R. J. (2014) MYC regulation of cell growth through control of transcription by RNA polymerases I and III. Cold Spring Harb. Perspect. Med. 4, a018408.
20. Edmunds, L. R., Sharma, L., Kang, A., Lu, J., Vockley, J., Basu, S., Uppala, R., Goetzman, E. S., Beck, M. E., Scott, D., and Prochownik, E. V. (2014) c-Myc programs fatty acid metabolism and dictates acetyl-CoA abundance and fate. J. Biol. Chem. 289, 25382-25392.
21. Edmunds, L. R., Sharma, L., Wang, H., Kang, A., d'Souza, S., Lu, J., McLaughlin, M., Dolezal, J. M., Gao, X., Weintraub, S. T., Ding, Y., Zeng, X., Yates, N., and Prochownik, E. V. (2015) c-Myc and AMPK control cellular energy levels by cooperatively regulating mitochondrial structure and function. PLoS ONE 10, e0134049.
22. Graves, J. A., Wang, Y., Sims-Lucas, S., Cherok, E., Rothermund, K., Branca, M. F., Elster, J., Beer-Stolz, D., Van Houten, B., Vockley, J., and Prochownik, E. V. (2012) Mitochondrial structure, function and dynamics are temporally controlled by c-Myc. PLoS ONE 7, e37699.
23. Hofmann, J. W., Zhao, X., De Cecco, M., Peterson, A. L., Pagliaroli, L., Manivannan, J., Hubbard, G. B., Ikeno, Y., Zhang, Y., Feng, B., Li, X., Serre, T., Qi, W., Van Remmen, H., Miller, R. A., et al. (2015) Reduced expression of MYC increases longevity and enhances healthspan. Cell 160, 477- 488.
24. Davis, A. C., Wims, M., Spotts, G. D., Hann, S. R., and Bradley, A. (1993) A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev. 7, 671-682.
25. Soucek, L., Whitfield, J., Martins, C. P., Finch, A. J., Murphy, D. J., Sodir, N. M., Karnezis, A. N., Swigart, L. B., Nasi, S., and Evan, G. I. (2008) Modelling Myc inhibition as a cancer therapy. Nature 455, 679-683.
26. Edmunds, L. R., Otero, P. A., Sharma, L., D'Souza, S., Dolezal, J. M., David, S., Lu, J., Lamm, L., Basantani, M., Zhang, P., Sipula, I. J., Li, L., Zeng, X., Ding, Y., Ding, F., et al. (2016) Abnormal lipid processing but normal long-Term repopulation potential of myc-/- hepatocytes. Oncotarget 7, 30379-30395.
27. Chen, X., and Calvisi, D. F. (2014) Hydrodynamic transfection for generation of novel mouse models for liver cancer research. Am. J. Pathol. 184, 912-923.
28. Nikiforov, M. A., Chandriani, S., O'Connell, B., Petrenko, O., Kotenko, I., Beavis, A., Sedivy, J. M., and Cole, M. D. (2002) A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism. Mol. Cell Biol. 22, 5793-5800.
29. Rothermund, K., Rogulski, K., Fernandes, E., Whiting, A., Sedivy, J., Pu, L., and Prochownik, E. V. (2005) C-Myc-independent restoration of multiple phenotypes by two C-Myc target genes with overlapping functions. Cancer Res. 65, 2097-2107.
30. Li, F., Wang, Y., Zeller, K. I., Potter, J. J., Wonsey, D. R., O'Donnell, K. A., Kim, J. W., Yustein, J. T., Lee, L. A., and Dang, C. V. (2005) Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol. Cell Biol. 25, 6225-6234.
31. Ward, P. S., and Thompson, C. B. (2012) Metabolic reprogramming: A cancer hallmark even Warburg did not anticipate. Cancer Cell 21, 297-308.
32. Klann, E., and Dever, T. E. (2004) Biochemical mechanisms for translational regulation in synaptic plasticity. Nat. Rev. Neurosci. 5, 931-942.
33. Livingstone, M., Atas, E., Meller, A., and Sonenberg, N. (2010) Mechanisms governing the control of mRNA translation. Phys. Biol. 7, 021001.
34. Lorbek, G., Lewinska, M., and Rozman, D. (2012) Cytochrome P450s in the synthesis of cholesterol and bile acids: from mouse models to human diseases. FEBS J. 279, 1516-1533.
35. Workman, J. L., and Kingston, R. E. (1998) Alteration of nucleosome structure as a mechanism of transcriptional regulation. Annu. Rev. Biochem. 67, 545-579.
36. Wise, D. R., and Thompson, C. B. (2010) Glutamine addiction: A new therapeutic target in cancer. Trends Biochem. Sci. 35, 427-433.
37. Stine, Z. E., Walton, Z. E., Altman, B. J., Hsieh, A. L., and Dang, C. V. (2015) MYC, metabolism, and cancer. Cancer Discov. 5, 1024-1039.
38. Landay, M., Oster, S. K., Khosravi, F., Grove, L. E., Yin, X., Sedivy, J., Penn, L. Z., and Prochownik, E. V. (2000) Promotion of growth and apoptosis in c-myc nullizygous fibroblasts by other members of the myc oncoprotein family. Cell Death Differ. 7, 697-705.
39. Barrett, J., Birrer, M. J., Kato, G. J., Dosaka-Akita, H., and Dang, C. V. (1992) Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells. Mol. Cell Biol. 12, 3130-3137.
40. Bhat, M., Robichaud, N., Hulea, L., Sonenberg, N., Pelletier, J., and Topisirovic, I. (2015) Targeting the translation machinery in cancer. Nat. Rev. Drug Discov. 14, 261-278.
41. van Riggelen, J., Yetil, A., and Felsher, D. W. (2010) MYC as a regulator of ribosome biogenesis and protein synthesis. Nat. Rev. Cancer 10, 301-309.
42. Leprivier, G., Rotblat, B., Khan, D., Jan, E., and Sorensen, P. H. (2015) Stress-mediated translational control in cancer cells. Biochim. Biophys. Acta 1849, 845-860.
43. Reznik, E., Miller, M. L., enbabaoglu, Y., Riaz, N., Sarungbam, J., Tickoo, S. K., Al-Ahmadie, H. A., Lee, W., Seshan, V. E., Hakimi, A. A., and Sander, C. (2016) Mitochondrial DNA copy number variation across human cancers. Elife 5, e10769.
44. Cai, L., Sutter, B. M., Li, B., and Tu, B. P. (2011) Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes. Mol. Cell 42, 426-437.
45. Vivanco, I. (2014) Targeting molecular addictions in cancer. Br. J. Cancer 111, 2033-203.
46. de Alboran, I. M., O'Hagan, R. C., Gartner, F., Malynn, B., Davidson, L., Rickert, R., Rajewsky, K., DePinho, R. A., and Alt, F. W. (2001) Analysis of C-MYC function in normal cells via conditional gene-Targeted mutation. Immunity 14, 45-55.
47. Eigentler, A., Draxl, A., Wiethuchter, A., Kuznetsov, A. V., Lassing, B., and Gnaiger, E. (2015) Laboratory protocol: Citrate synthase: A mitochondrial marker enzyme. Mitochondrial Physiology Network 17.04, 1-11.
48. Edgar, R., Domrachev, M., and Lash, A. E. (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30, 207-210.
49. Bligh, E. G., and Dyer, W. J. (1959) A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917.
50. Trinei, M., Berniakovich, I., Pelicci, P. G., and Giorgio, M. (2006) Mitochondrial DNA copy number is regulated by cellular proliferation: A role for Ras and p66Shc. Biochim. Biophys. Acta 1757, 624-630.